Sentences with phrase «abnormal blood vessel growth»

Retinopathy of prematurity is caused by abnormal blood vessel growth near the retina, the light - sensitive portion in the back of an eye.

Currently, wet AMD patients are treated with frequent (as often as once a month) injections into the eye of a drug that blocks one of the major stimulators of abnormal blood vessel growth.

Roughly 20 percent of patients with age - related macular degeneration suffer from abnormal blood vessel growth and vascular leakage, says Campochiaro, and so may be helped by this new therapy, if it proves to work in clinical trials.

«Finding a way to control angiogenesis not only provides a target for the development of anti-cancer therapies, but may also prove useful in similarly starving abnormal blood vessel growth elsewhere in the body, like in diabetic eye disease.»

In the less common wet AMD, something (scientists aren't sure what) spurs abnormal blood vessel growth, and central vision can be lost in a matter of weeks or days.

For wet AMD, treatments aimed at stopping abnormal blood vessel growth include FDA - approved drugs called Lucentis, Eylea, Macugen and Visudyne used with Photodynamic Therapy or PDT.

Ultimately, Wars2 provides researchers and pharmaceutical companies a fresh new target for developing treatments for diseases characterized by abnormal blood vessel growth that may be more effective and specific or complementary to what is currently available.

If your baby was born prematurely — especially if he was very premature, had an infection, or needed treatment with oxygen — he's at greater risk for developing certain eye problems, including astigmatism (blurred vision), myopia (nearsightedness), retinopathy of prematurity (abnormal blood vessel growth that can lead to blindness), and strabismus (eye misalignment).

Working with mice, a multicenter team of researchers has found a new way to reduce the abnormal blood vessel growth and leakage in the eye that accompany some eye diseases.

Further research also will help determine which if any of these drugs is safer for glaucoma patients who also have abnormal blood vessel growth.

Choroidal neovascularization (CNV), the underlying process causing wet AMD and abnormal blood vessel growth, is the body's misguided way of attempting to create a new network of blood vessels to supply more nutrients and oxygen to the eye's retina.

When we injected this compound into the eye we saw no signs of toxicity by a number of different measures, and that gave us the confidence to test it in an animal model of choroidal neovascularization (CNV), which is the even more technical term for the angiogenesis, the abnormal blood vessel growth that occurs in wet AMD.

That was the research niche that we set out to explore to see if we could find a new way of targeting the abnormal blood vessel growth that occurs in wet AMD.